This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Teva-Lorazepam 0.5 mg (2017-02-09)

Starting date:: February 9, 2017
Posting date:: February 23, 2017
Type of communication:: Drug Recall
Subcategory:: Drugs
Hazard classification:: Type III
Source of recall:: Health Canada
Issue:: Product Safety
Audience:: General Public, Healthcare Professionals, Hospitals
Identification number:: RA-62294

Reason
Depth of distribution
Affected products

Reason

Out of specification result for Organic Impurity - USP Related Compound C during stability testing.

Depth of distribution

Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Ontario, Quebec and Saskatchewan.

Affected products